Aurora Cannabis Announces CFO Transition, Completes Prior Transaction

TL;DR

**Aurora Cannabis is changing CFOs and just closed a deal, expect potential shifts in financial direction.**

AI Summary

Aurora Cannabis Inc. announced a CFO transition on February 20, 2024, with Simona King stepping down as Chief Financial Officer. The company also confirmed the completion of a previously announced transaction, though specific details of that transaction were not provided in this filing. Miguel Martin, CEO, signed the report.

Why It Matters

This filing signals a significant change in Aurora Cannabis's executive leadership, which could impact financial strategy and investor confidence, and confirms the finalization of an undisclosed prior business move.

Risk Assessment

Risk Level: medium — A CFO transition can introduce uncertainty regarding a company's financial strategy and reporting, potentially impacting investor perception.

Key Players & Entities

• Aurora Cannabis Inc. (company) — registrant
• Miguel Martin (person) — Chief Executive Officer
• Simona King (person) — outgoing Chief Financial Officer
• February 20, 2024 (date) — date of filing and news release

FAQ

From the Filing

0001279569-24-000161.txt : 20240220 0001279569-24-000161.hdr.sgml : 20240220 20240220073630 ACCESSION NUMBER: 0001279569-24-000161 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 24650726 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 3498 63 Avenue, Leduc, Alberta, Canada T9E 0G8 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated February 20, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: February 20, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED FEBRUARY 20, 2024 Exhibit 99.1 Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation NASDAQ | TSX: ACB EDMONTON, AB, Feb. 20, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is pleased to announce today that Simona King, a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer of the Company, effective February 21, 2024. Ms. King brings over 25 years of progressive finance leadership experience, with deep business knowledge and proven success with global and emerging organizations. She served nearly 20 years with Bristol Myers-Squibb, where she held increasingly senior finance roles and enabled the company's growth strategy. Glen Ibbott, current Chief Financial Officer, will be stepping down from his full-time role effective today to pursue new opportunities. He will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Simona. CFO Transition "As our company continues to evolve, we are thrilled to welcome Simona King to Aurora. Simona has spent her career growing businesses, improving operational efficiencies, and leading a best- in-class global financial organization. Her deep operational and financial knowledge, combined with her extensive experience across many corporate functions and deep commitment to developing talent, make her uniquely positioned to help lead Aurora into its next phase of growth" said Miguel Martin, CEO. Mr. Martin continued, "On behalf of our Board of Directors, and the entire Aurora team, I would like to offer our sincere thanks and appreciation to Glen. Since 2017, Glen has dedicated immeasurable time, energy, and passion to shaping Aurora into a leading medical cannabis company; and we have been fortunate to have his leadership over the years as we navigated this emerging industry. We wish him all the best for his future endeavours."